1. Home
  2. TRVI vs ANDE Comparison

TRVI vs ANDE Comparison

Compare TRVI & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$17.93

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Andersons Inc. (The)

ANDE

Andersons Inc. (The)

HOLD

Current Price

$66.30

Market Cap

2.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVI
ANDE
Founded
2011
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.4B
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
TRVI
ANDE
Price
$17.93
$66.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
2
Target Price
$21.55
$75.00
AVG Volume (30 Days)
2.2M
312.3K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
1.03%
EPS Growth
31.91
12.93
EPS
N/A
0.97
Revenue
N/A
$11,008,928,000.00
Revenue This Year
N/A
$7.28
Revenue Next Year
N/A
$3.57
P/E Ratio
N/A
$69.45
Revenue Growth
N/A
N/A
52 Week Low
$5.78
$31.84
52 Week High
$19.26
$82.11

Technical Indicators

Market Signals
Indicator
TRVI
ANDE
Relative Strength Index (RSI) 66.24 33.98
Support Level $10.07 $66.03
Resistance Level N/A $74.24
Average True Range (ATR) 1.00 2.02
MACD 0.18 -0.41
Stochastic Oscillator 77.37 3.68

Price Performance

Historical Comparison
TRVI
ANDE

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

About ANDE Andersons Inc. (The)

Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.

Share on Social Networks: